LDN (Low Dose Naltrexone)
The brief blockade of opioid receptors between 2 a.m. and 4 a.m. that is caused by taking LDN at bedtime each night is believed to produce a prolonged up-regulation of vital elements of the immune system by causing an increase in endorphin and encephalin production.
Low Dose Naltrexone (LDN) may well be the most important therapeutic breakthrough in over fifty years. It provides a new, safe and inexpensive method of medical treatment by mobilizing the natural defenses of one’s own immune system.
LDN substantially reduces health care costs and improves treatment of a wide array of diseases. Unfortunately, because naltrexone has been without patent protection for many years, no pharmaceutical company will bear the expense of the large clinical trials necessary for FDA approval of LDN’s new special uses. It is now up to public institutions to seize the opportunity that LDN offers.” —
David Gluck, MD
What diseases has it been useful for and how effective is it?
- Restless Leg Syndrome
- ALS (Lou Gehrig’s Disease)
- Alzheimer’s Disease· Ankylosing Spondylitis·
- Autism Spectrum Disorders
- Celiac Disease
- Chronic Fatigue Syndrome·
- Crohn’s Disease
- Irritable Bowel Syndrome (IBS)
- Multiple Sclerosis (MS)
- Parkinson’s Disease
- Psoriasis· Rheumatoid Arthritis
- Systemic Lupus (SLE)
- Ulcerative Colitis